BACKGROUND: Mutations in FKTN encoding for fukutin cause Fukuyama-type congenital muscular dystrophy characterized by severe muscle wasting and hypotonia with mental retardation. Fukuyama-type congenital muscular dystrophy is a recessive genetic trait. FKTN mutations in patients with dilated cardiomyopathy (DCM) have been investigated by our research group. The patients showed hyper-CKemia with mild or no muscle weakness and without mental retardation, suggesting that the clinical spectrum of FKTN mutations are wider than previously thought. The current study was designed to further explore the association of FKTN mutations with DCM or hypertrophic cardiomyopathy (HCM). METHODS AND RESULTS: A total of 172 patients with DCM, 144 patients with familial HCM and 384 control individuals were analyzed for FKTN mutations. There was a DCM patient who was a compound heterozygote of a 3-kb insertion mutation and a missense mutation Cys101Phe. The patient showed hyper-CKemia with mild muscle involvement and no brain involvement. In contrast, 2 other DCM patients and 3 controls were heterozygous for the insertion mutation and normal allele, showing that the heterozygous insertion mutation itself was not associated with DCM. No mutation was found in the HCM patients. CONCLUSIONS: These observations indicated that the compound heterozygous FKTN mutation was a rare cause of DCM. Hyper-CKemia might be indicative of FKTN mutation in DCM.
BACKGROUND: Mutations in FKTN encoding for fukutin cause Fukuyama-type congenital muscular dystrophy characterized by severe muscle wasting and hypotonia with mental retardation. Fukuyama-type congenital muscular dystrophy is a recessive genetic trait. FKTN mutations in patients with dilated cardiomyopathy (DCM) have been investigated by our research group. The patients showed hyper-CKemia with mild or no muscle weakness and without mental retardation, suggesting that the clinical spectrum of FKTN mutations are wider than previously thought. The current study was designed to further explore the association of FKTN mutations with DCM or hypertrophic cardiomyopathy (HCM). METHODS AND RESULTS: A total of 172 patients with DCM, 144 patients with familial HCM and 384 control individuals were analyzed for FKTN mutations. There was a DCMpatient who was a compound heterozygote of a 3-kb insertion mutation and a missense mutation Cys101Phe. The patient showed hyper-CKemia with mild muscle involvement and no brain involvement. In contrast, 2 other DCMpatients and 3 controls were heterozygous for the insertion mutation and normal allele, showing that the heterozygous insertion mutation itself was not associated with DCM. No mutation was found in the HCM patients. CONCLUSIONS: These observations indicated that the compound heterozygous FKTN mutation was a rare cause of DCM. Hyper-CKemia might be indicative of FKTN mutation in DCM.
Authors: Klaus Stark; Ulrike B Esslinger; Wibke Reinhard; George Petrov; Thomas Winkler; Michel Komajda; Richard Isnard; Philippe Charron; Eric Villard; François Cambien; Laurence Tiret; Marie-Claude Aumont; Olivier Dubourg; Jean-Noël Trochu; Laurent Fauchier; Pascal Degroote; Anette Richter; Bernhard Maisch; Thomas Wichter; Christa Zollbrecht; Martina Grassl; Heribert Schunkert; Patrick Linsel-Nitschke; Jeanette Erdmann; Jens Baumert; Thomas Illig; Norman Klopp; H-Erich Wichmann; Christa Meisinger; Wolfgang Koenig; Peter Lichtner; Thomas Meitinger; Arne Schillert; Inke R König; Roland Hetzer; Iris M Heid; Vera Regitz-Zagrosek; Christian Hengstenberg Journal: PLoS Genet Date: 2010-10-21 Impact factor: 5.917
Authors: Jessica R Golbus; Megan J Puckelwartz; Lisa Dellefave-Castillo; John P Fahrenbach; Viswateja Nelakuditi; Lorenzo L Pesce; Peter Pytel; Elizabeth M McNally Journal: Circ Cardiovasc Genet Date: 2014-09-01
Authors: Robert Lesurf; Abdelrahman Said; Oyediran Akinrinade; Jeroen Breckpot; Kathleen Delfosse; Ting Liu; Roderick Yao; Gabrielle Persad; Fintan McKenna; Ramil R Noche; Winona Oliveros; Kaia Mattioli; Shreya Shah; Anastasia Miron; Qian Yang; Guoliang Meng; Michelle Chan Seng Yue; Wilson W L Sung; Bhooma Thiruvahindrapuram; Jane Lougheed; Erwin Oechslin; Tapas Mondal; Lynn Bergin; John Smythe; Shashank Jayappa; Vinay J Rao; Jayaprakash Shenthar; Perundurai S Dhandapany; Christopher Semsarian; Robert G Weintraub; Richard D Bagnall; Jodie Ingles; Marta Melé; Philipp G Maass; James Ellis; Stephen W Scherer; Seema Mital Journal: NPJ Genom Med Date: 2022-03-14 Impact factor: 8.617